advertisement

---

Pharmaceutics 11

Showing records 1 to 11 | Display all abstracts in Pharmaceutics

106168 Recent Advances in Ophthalmic Drug Delivery
Chauhan A
Pharmaceutics 2022; 14:

---

106471 Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery
Luo J
Pharmaceutics 2022; 14:

---

106472 Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases
Nguyen H
Pharmaceutics 2022; 14:

---

106169 Aqueous Prostaglandin Eye Drop Formulations
Jansook P
Pharmaceutics 2022; 14:

---

106472 Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases
Lee SJ
Pharmaceutics 2022; 14:

---

106169 Aqueous Prostaglandin Eye Drop Formulations
Loftsson T
Pharmaceutics 2022; 14:

---

106168 Recent Advances in Ophthalmic Drug Delivery
Fitzhenry L
Pharmaceutics 2022; 14:

---

106471 Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery
Tan G; Thong KX
Pharmaceutics 2022; 14:

---

106472 Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases
Li Y
Pharmaceutics 2022; 14:

---

106168 Recent Advances in Ophthalmic Drug Delivery
Serro AP
Pharmaceutics 2022; 14:

---

106471 Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery
Kafetzis KN; Vallabh N; Sheridan CM; Sato Y; Harashima H; Tagalakis AD; Yu-Wai-Man C
Pharmaceutics 2022; 14:

---